Brant Point Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.63M | Buy |
17,221
+1,334
| +8% | +$640K | 1.06% | 16 |
|
|
2026
Q1 | $7.81M | Buy |
15,887
+58
| +0.4% | +$31.5K | 1.01% | 18 |
|
|
2025
Q4 | $9.17M | Hold |
15,829
| – | – | 1.11% | 16 |
|
|
2025
Q3 | $7.68M | Sell |
15,829
-2,000
| -11% | -$931K | 0.83% | 20 |
|
|
2025
Q2 | $7.23M | Buy |
17,829
+1,032
| +6% | +$431K | 0.76% | 20 |
|
|
2025
Q1 | $8.36M | Buy |
16,797
+108
| +0.6% | +$58.5K | 1% | 17 |
|
|
2024
Q4 | $8.68M | Buy |
16,689
+1,710
| +11% | +$940K | 1.08% | 15 |
|
|
2024
Q3 | $9.27M | Hold |
14,979
| – | – | 1.02% | 19 |
|
|
2024
Q2 | $8.28M | Sell |
14,979
-46
| -0.3% | -$26.4K | 0.74% | 22 |
|
|
2024
Q1 | $8.73M | Buy |
15,025
+107
| +0.7% | +$60K | 0.73% | 22 |
|
|
2023
Q4 | $7.92M | Sell |
14,918
-1,258
| -8% | -$609K | 0.64% | 25 |
|
|
2023
Q3 | $8.19M | Sell |
16,176
-211
| -1% | -$112K | 0.77% | 23 |
|
|
2023
Q2 | $8.55M | Buy |
16,387
+945
| +6% | +$510K | 1.96% | 20 |
|
|
2023
Q1 | $8.9M | Hold |
15,442
| – | – | 1.48% | 20 |
|
|
2022
Q4 | $8.5M | Sell |
15,442
-8,796
| -36% | -$4.66M | 1.25% | 17 |
|
|
2022
Q3 | $12.3M | Buy |
24,238
+1,000
| +4% | +$560K | 1.81% | 10 |
|
|
2022
Q2 | $12.6M | Buy |
23,238
+7,753
| +50% | +$4.27M | 1.87% | 7 |
|
|
2022
Q1 | $9.15M | Hold |
15,485
| – | – | 1.04% | 19 |
|
|
2021
Q4 | $10.3M | Buy |
15,485
+49
| +0.3% | +$30.6K | 1.62% | 11 |
|
|
2021
Q3 | $8.82M | Buy |
15,436
+49
| +0.3% | +$26.9K | 0.76% | 21 |
|
|
2021
Q2 | $7.76M | Hold |
15,387
| – | – | 0.72% | 26 |
|
|
2021
Q1 | $7.02M | Sell |
15,387
-7,000
| -31% | -$3.34M | 0.77% | 31 |
|
|
2020
Q4 | $10.4M | Sell |
22,387
-3,000
| -12% | -$1.41M | 1.23% | 8 |
|
|
2020
Q3 | $11.2M | Hold |
25,387
| – | – | 0.97% | 8 |
|
|
2020
Q2 | $9.2M | Hold |
25,387
| – | – | 0.91% | 14 |
|
|
2020
Q1 | $7.2M | Buy |
25,387
+2,100
| +9% | +$662K | 0.91% | 18 |
|
|
2019
Q4 | $7.57M | Buy |
23,287
+49
| +0.2% | +$14.9K | 0.77% | 22 |
|
|
2019
Q3 | $6.77M | Hold |
23,238
| – | – | 0.66% | 29 |
|
|
2019
Q2 | $6.83M | Hold |
23,238
| – | – | 0.66% | 27 |
|
|
2019
Q1 | $6.36M | Buy |
23,238
+177
| +0.8% | +$44K | 0.8% | 22 |
|
|
2018
Q4 | $5.16M | Hold |
23,061
| – | – | 0.75% | 28 |
|
|
2018
Q3 | $5.63M | Hold |
23,061
| – | – | 0.53% | 37 |
|
|
2018
Q2 | $4.78M | Hold |
23,061
| – | – | 0.39% | 54 |
|
|
2018
Q1 | $4.76M | Buy |
23,061
+117
| +0.5% | +$24.6K | 0.35% | 52 |
|
|
2017
Q4 | $4.36M | Sell |
22,944
-1,556
| -6% | -$298K | 0.44% | 52 |
|
|
2017
Q3 | $4.63M | Sell |
24,500
-400
| -2% | -$72.4K | 0.48% | 53 |
|
|
2017
Q2 | $4.34M | Hold |
24,900
| – | – | 0.53% | 57 |
|
|
2017
Q1 | $3.83M | Sell |
24,900
-125
| -0.5% | -$19.1K | 0.39% | 74 |
|
|
2016
Q4 | $3.53M | Sell |
25,025
-1,075
| -4% | -$158K | 0.34% | 79 |
|
|
2016
Q3 | $4.15M | Buy |
26,100
+300
| +1% | +$46.2K | 0.36% | 68 |
|
|
2016
Q2 | $3.81M | Buy |
25,800
+300
| +1% | +$44.3K | 0.36% | 65 |
|
|
2016
Q1 | $3.61M | Hold |
25,500
| – | – | 0.37% | 67 |
|
|
2015
Q4 | $3.62M | Hold |
25,500
| – | – | 0.41% | 61 |
|
|
2015
Q3 | $3.12M | Buy |
25,500
+500
| +2% | +$65.1K | 0.35% | 73 |
|
|
2015
Q2 | $3.24M | Hold |
25,000
| – | – | 0.29% | 90 |
|
|
2015
Q1 | $3.36M | Sell |
25,000
-29,200
| -54% | -$3.76M | 0.3% | 88 |
|
|
2014
Q4 | $6.79M | Sell |
54,200
-10,000
| -16% | -$1.22M | 0.63% | 42 |
|
|
2014
Q3 | $7.81M | Sell |
64,200
-800
| -1% | -$97.3K | 0.74% | 37 |
|
|
2014
Q2 | $7.67M | Sell |
65,000
-33,900
| -34% | -$3.99M | 0.69% | 32 |
|
|
2014
Q1 | $11.9M | Sell |
98,900
-5,000
| -5% | -$594K | 1.14% | 12 |
|
|
2013
Q4 | $11.6M | Buy |
103,900
+42,400
| +69% | +$4.22M | 1.05% | 20 |
|
|
2013
Q3 | $5.67M | Sell |
61,500
-20,000
| -25% | -$1.81M | 0.64% | 44 |
|
|
2013
Q2 | $6.9M | Buy |
+81,500
| New | +$6.78M | 0.75% | 38 |
|
Other funds holding TMO
Brant Point Investment Management's TMO Position: Q2 2026 in Review
Brant Point Investment Management increased its Thermo Fisher Scientific (TMO) stake by 8.4% in Q2 2026, buying an estimated $640K and bringing the position to 17,221 shares worth $8.63M. The position accounts for 1.06% of the portfolio, ranked #16.
Brant Point Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.6M in Q2 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Brant Point Investment Management held 17,221 shares of Thermo Fisher Scientific worth $8.63M as of Q2 2026.
- Brant Point Investment Management bought 1,334 Thermo Fisher Scientific shares in Q2 2026, an estimated $640K.
- Thermo Fisher Scientific made up 1.06% of Brant Point Investment Management's portfolio in Q2 2026, its #16 holding.
- Brant Point Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Brant Point Investment Management's Thermo Fisher Scientific position peaked at $12.6M in Q2 2022.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Brant Point Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.